Clinical Trials Browser

Completed × Acromegaly × Endocrine × Clear all

Acromegaly, Pituitary Neoplasms

NCT06253897 2024-12-24

BackSOM

Completed

20 enrolled

EndocrineGastrointestinalNET

Gastro-enteropancreatic neuroendocrine tumor, Acromegaly

NCT01794793 2024-10-01

Study to Allow Access to Pasireotide for Patients Benefiting From Pasireotide Treatment in Novartis-sponsored Studies

Phase 4 Completed

337 enrolled 8 charts

DermatologicEndocrineGenitourinaryNET

Acromegaly, Dumping Syndrome, Melanoma, Neoplasms, Pituitary Neoplasms, Prostatic Neoplasms, Neuroendocrine Tumors, Pituitary ACTH Hypersecretion

NCT00446082 2020-12-21

Study of Pasireotide Long Acting Release (LAR) Injection in Patients With Acromegaly and Patients With Carcinoid Disease

Phase 1 Completed

85 enrolled

Endocrine

Acromegaly, Carcinoid Tumor

NCT00001981 2020-11-27

The Treatment and Natural History of Acromegaly

Completed

117 enrolled

Endocrine

Acromegaly, Pituitary Neoplasms

NCT02354508 2019-12-10

Pasireotide in Patients With Acromegaly Inadequately Controlled With First Generation Somatostatin Analogues

Phase 3 Completed

123 enrolled 27 charts

Endocrine

Acromegaly, Gigantism, Growth Disorders, Pituitary Neoplasms

NCT01673646 2019-09-16

Efficacy and Safety of Pasireotide LAR (Long-acting Release) in Japanese Patients With Acromegaly or Pituitary Gigantism

Phase 2 Completed

33 enrolled 24 charts

Endocrine

Acromegaly, Gigantism, Growth Disorders, Pituitary Neoplasms

NCT01840449 2019-01-14

SOPRANo

Completed

156 enrolled

EndocrineNET

Acromegaly, Neuroendocrine Tumors

NCT01504399 2018-08-22

Rhinological Outcomes in Endonasal Pituitary Surgery

Completed

235 enrolled

Endocrine

Acromegaly, Adrenocortical Hyperfunction, Pituitary Neoplasms, Prolactinoma

NCT01137682 2018-04-05

PAOLA

Phase 3 Completed

198 enrolled 17 charts

Endocrine

Acromegaly, Pituitary Neoplasms

NCT02299089 2017-12-15

Phase II Study of Subcutaneous Inj. Depot of Octreotide in Patients With Acromegaly and Neuroendocrine Tumours (NETs)

Phase 2 Completed

12 enrolled 18 charts

EndocrineNET

Acromegaly, Neuroendocrine Tumors, Serotonin Syndrome

NCT00376064 2017-03-06

Efficacy of Octreotide Acetate and Cabergoline in Patients With Acromegaly

Phase 4 Completed

20 enrolled

CNSEndocrine

Acromegaly, Brain Neoplasms, Pituitary Neoplasms

NCT01029275 2014-07-31

SAPORO

Phase NA Completed

89 enrolled

Endocrine

Acromegaly, Pituitary Neoplasms

NCT00001860 2008-03-04

Sandostatin LAR Depot vs. Surgery for Treating Acromegaly

Phase 2 Completed

5 enrolled

Endocrine

Acromegaly, Pituitary Neoplasms

NCT00461149 2007-04-17

HDacro

Phase 4 Completed

50 enrolled

Endocrine

Acromegaly, Pituitary Neoplasms

Clinical Trials

A Prospective Study of Outcome After Therapy for Acromegaly

BackSOM

Study to Allow Access to Pasireotide for Patients Benefiting From Pasireotide Treatment in Novartis-sponsored Studies

Study of Pasireotide Long Acting Release (LAR) Injection in Patients With Acromegaly and Patients With Carcinoid Disease

The Treatment and Natural History of Acromegaly

Pasireotide in Patients With Acromegaly Inadequately Controlled With First Generation Somatostatin Analogues

Efficacy and Safety of Pasireotide LAR (Long-acting Release) in Japanese Patients With Acromegaly or Pituitary Gigantism

SOPRANo

Rhinological Outcomes in Endonasal Pituitary Surgery

PAOLA

Phase II Study of Subcutaneous Inj. Depot of Octreotide in Patients With Acromegaly and Neuroendocrine Tumours (NETs)

Efficacy of Octreotide Acetate and Cabergoline in Patients With Acromegaly

SAPORO

Sandostatin LAR Depot vs. Surgery for Treating Acromegaly

HDacro